Global Invasive Candidiasis Treatment Drug Market Research Report 2026(Status and Outlook)
The global Invasive Candidiasis Treatment Drug market size was estimated at USD 1048.5 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.45% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Invasive Candidiasis Treatment Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Invasive Candidiasis Treatment Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Invasive Candidiasis Treatment Drug market.
Global Invasive Candidiasis Treatment Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GlaxoSmithKline
Merck & Co., Inc
Pfizer Inc
Cidara Therapeutics, Inc
Astellas Pharma Inc
Gilead Sciences, Inc
Novo Nordisk A/S (Xellia Pharmaceuticals)
Biosergen AB
Matinas BioPharma Holdings, Inc
Pulmocide Ltd
F2G Ltd
Market Segmentation (by Type)
Azoles Drug
Echinocandins Drug
Allylamines Drug
Polyenes Drug
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Invasive Candidiasis Treatment Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Invasive Candidiasis Treatment Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
This report offers a comprehensive and in-depth analysis of the global Invasive Candidiasis Treatment Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Invasive Candidiasis Treatment Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Invasive Candidiasis Treatment Drug market.
Global Invasive Candidiasis Treatment Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
GlaxoSmithKline
Merck & Co., Inc
Pfizer Inc
Cidara Therapeutics, Inc
Astellas Pharma Inc
Gilead Sciences, Inc
Novo Nordisk A/S (Xellia Pharmaceuticals)
Biosergen AB
Matinas BioPharma Holdings, Inc
Pulmocide Ltd
F2G Ltd
Market Segmentation (by Type)
Azoles Drug
Echinocandins Drug
Allylamines Drug
Polyenes Drug
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Invasive Candidiasis Treatment Drug Market
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Invasive Candidiasis Treatment Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Invasive Candidiasis Treatment Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Invasive Candidiasis Treatment Drug
1.2 Key Market Segments
1.2.1 Invasive Candidiasis Treatment Drug Segment by Type
1.2.2 Invasive Candidiasis Treatment Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Invasive Candidiasis Treatment Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Invasive Candidiasis Treatment Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Invasive Candidiasis Treatment Drug Product Life Cycle
3.3 Global Invasive Candidiasis Treatment Drug Sales by Manufacturers (2020-2025)
3.4 Global Invasive Candidiasis Treatment Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Invasive Candidiasis Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Invasive Candidiasis Treatment Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Invasive Candidiasis Treatment Drug Market Competitive Situation and Trends
3.8.1 Invasive Candidiasis Treatment Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Invasive Candidiasis Treatment Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INVASIVE CANDIDIASIS TREATMENT DRUG INDUSTRY CHAIN ANALYSIS
4.1 Invasive Candidiasis Treatment Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INVASIVE CANDIDIASIS TREATMENT DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Invasive Candidiasis Treatment Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Invasive Candidiasis Treatment Drug Market
5.7 ESG Ratings of Leading Companies
6 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Invasive Candidiasis Treatment Drug Sales Market Share by Type (2020-2025)
6.3 Global Invasive Candidiasis Treatment Drug Market Size by Type (2020-2025)
6.4 Global Invasive Candidiasis Treatment Drug Price by Type (2020-2025)
7 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Invasive Candidiasis Treatment Drug Market Sales by Application (2020-2025)
7.3 Global Invasive Candidiasis Treatment Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Invasive Candidiasis Treatment Drug Sales Growth Rate by Application (2020-2025)
8 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET SALES BY REGION
8.1 Global Invasive Candidiasis Treatment Drug Sales by Region
8.1.1 Global Invasive Candidiasis Treatment Drug Sales by Region
8.1.2 Global Invasive Candidiasis Treatment Drug Sales Market Share by Region
8.2 Global Invasive Candidiasis Treatment Drug Market Size by Region
8.2.1 Global Invasive Candidiasis Treatment Drug Market Size by Region
8.2.2 Global Invasive Candidiasis Treatment Drug Market Size by Region
8.3 North America
8.3.1 North America Invasive Candidiasis Treatment Drug Sales by Country
8.3.2 North America Invasive Candidiasis Treatment Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Invasive Candidiasis Treatment Drug Sales by Country
8.4.2 Europe Invasive Candidiasis Treatment Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Invasive Candidiasis Treatment Drug Sales by Region
8.5.2 Asia Pacific Invasive Candidiasis Treatment Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Invasive Candidiasis Treatment Drug Sales by Country
8.6.2 South America Invasive Candidiasis Treatment Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Invasive Candidiasis Treatment Drug Sales by Region
8.7.2 Middle East and Africa Invasive Candidiasis Treatment Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Invasive Candidiasis Treatment Drug by Region(2020-2025)
9.2 Global Invasive Candidiasis Treatment Drug Revenue Market Share by Region (2020-2025)
9.3 Global Invasive Candidiasis Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Invasive Candidiasis Treatment Drug Production
9.4.1 North America Invasive Candidiasis Treatment Drug Production Growth Rate (2020-2025)
9.4.2 North America Invasive Candidiasis Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Invasive Candidiasis Treatment Drug Production
9.5.1 Europe Invasive Candidiasis Treatment Drug Production Growth Rate (2020-2025)
9.5.2 Europe Invasive Candidiasis Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Invasive Candidiasis Treatment Drug Production (2020-2025)
9.6.1 Japan Invasive Candidiasis Treatment Drug Production Growth Rate (2020-2025)
9.6.2 Japan Invasive Candidiasis Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Invasive Candidiasis Treatment Drug Production (2020-2025)
9.7.1 China Invasive Candidiasis Treatment Drug Production Growth Rate (2020-2025)
9.7.2 China Invasive Candidiasis Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Basic Information
10.1.2 GlaxoSmithKline Invasive Candidiasis Treatment Drug Product Overview
10.1.3 GlaxoSmithKline Invasive Candidiasis Treatment Drug Product Market Performance
10.1.4 GlaxoSmithKline Business Overview
10.1.5 GlaxoSmithKline SWOT Analysis
10.1.6 GlaxoSmithKline Recent Developments
10.2 Merck and Co., Inc
10.2.1 Merck and Co., Inc Basic Information
10.2.2 Merck and Co., Inc Invasive Candidiasis Treatment Drug Product Overview
10.2.3 Merck and Co., Inc Invasive Candidiasis Treatment Drug Product Market Performance
10.2.4 Merck and Co., Inc Business Overview
10.2.5 Merck and Co., Inc SWOT Analysis
10.2.6 Merck and Co., Inc Recent Developments
10.3 Pfizer Inc
10.3.1 Pfizer Inc Basic Information
10.3.2 Pfizer Inc Invasive Candidiasis Treatment Drug Product Overview
10.3.3 Pfizer Inc Invasive Candidiasis Treatment Drug Product Market Performance
10.3.4 Pfizer Inc Business Overview
10.3.5 Pfizer Inc SWOT Analysis
10.3.6 Pfizer Inc Recent Developments
10.4 Cidara Therapeutics, Inc
10.4.1 Cidara Therapeutics, Inc Basic Information
10.4.2 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product Overview
10.4.3 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product Market Performance
10.4.4 Cidara Therapeutics, Inc Business Overview
10.4.5 Cidara Therapeutics, Inc Recent Developments
10.5 Astellas Pharma Inc
10.5.1 Astellas Pharma Inc Basic Information
10.5.2 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product Overview
10.5.3 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product Market Performance
10.5.4 Astellas Pharma Inc Business Overview
10.5.5 Astellas Pharma Inc Recent Developments
10.6 Gilead Sciences, Inc
10.6.1 Gilead Sciences, Inc Basic Information
10.6.2 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product Overview
10.6.3 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product Market Performance
10.6.4 Gilead Sciences, Inc Business Overview
10.6.5 Gilead Sciences, Inc Recent Developments
10.7 Novo Nordisk A/S (Xellia Pharmaceuticals)
10.7.1 Novo Nordisk A/S (Xellia Pharmaceuticals) Basic Information
10.7.2 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product Overview
10.7.3 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product Market Performance
10.7.4 Novo Nordisk A/S (Xellia Pharmaceuticals) Business Overview
10.7.5 Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Developments
10.8 Biosergen AB
10.8.1 Biosergen AB Basic Information
10.8.2 Biosergen AB Invasive Candidiasis Treatment Drug Product Overview
10.8.3 Biosergen AB Invasive Candidiasis Treatment Drug Product Market Performance
10.8.4 Biosergen AB Business Overview
10.8.5 Biosergen AB Recent Developments
10.9 Matinas BioPharma Holdings, Inc
10.9.1 Matinas BioPharma Holdings, Inc Basic Information
10.9.2 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product Overview
10.9.3 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product Market Performance
10.9.4 Matinas BioPharma Holdings, Inc Business Overview
10.9.5 Matinas BioPharma Holdings, Inc Recent Developments
10.10 Pulmocide Ltd
10.10.1 Pulmocide Ltd Basic Information
10.10.2 Pulmocide Ltd Invasive Candidiasis Treatment Drug Product Overview
10.10.3 Pulmocide Ltd Invasive Candidiasis Treatment Drug Product Market Performance
10.10.4 Pulmocide Ltd Business Overview
10.10.5 Pulmocide Ltd Recent Developments
10.11 F2G Ltd
10.11.1 F2G Ltd Basic Information
10.11.2 F2G Ltd Invasive Candidiasis Treatment Drug Product Overview
10.11.3 F2G Ltd Invasive Candidiasis Treatment Drug Product Market Performance
10.11.4 F2G Ltd Business Overview
10.11.5 F2G Ltd Recent Developments
11 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET FORECAST BY REGION
11.1 Global Invasive Candidiasis Treatment Drug Market Size Forecast
11.2 Global Invasive Candidiasis Treatment Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Invasive Candidiasis Treatment Drug Market Size Forecast by Country
11.2.3 Asia Pacific Invasive Candidiasis Treatment Drug Market Size Forecast by Region
11.2.4 South America Invasive Candidiasis Treatment Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Invasive Candidiasis Treatment Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Invasive Candidiasis Treatment Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Invasive Candidiasis Treatment Drug by Type (2026-2035)
12.1.2 Global Invasive Candidiasis Treatment Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Invasive Candidiasis Treatment Drug by Type (2026-2035)
12.2 Global Invasive Candidiasis Treatment Drug Market Forecast by Application (2026-2035)
12.2.1 Global Invasive Candidiasis Treatment Drug Sales (K Units) Forecast by Application
12.2.2 Global Invasive Candidiasis Treatment Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Invasive Candidiasis Treatment Drug
1.2 Key Market Segments
1.2.1 Invasive Candidiasis Treatment Drug Segment by Type
1.2.2 Invasive Candidiasis Treatment Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Invasive Candidiasis Treatment Drug Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Invasive Candidiasis Treatment Drug Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Invasive Candidiasis Treatment Drug Product Life Cycle
3.3 Global Invasive Candidiasis Treatment Drug Sales by Manufacturers (2020-2025)
3.4 Global Invasive Candidiasis Treatment Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Invasive Candidiasis Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Invasive Candidiasis Treatment Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Invasive Candidiasis Treatment Drug Market Competitive Situation and Trends
3.8.1 Invasive Candidiasis Treatment Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Invasive Candidiasis Treatment Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 INVASIVE CANDIDIASIS TREATMENT DRUG INDUSTRY CHAIN ANALYSIS
4.1 Invasive Candidiasis Treatment Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF INVASIVE CANDIDIASIS TREATMENT DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Invasive Candidiasis Treatment Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Invasive Candidiasis Treatment Drug Market
5.7 ESG Ratings of Leading Companies
6 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Invasive Candidiasis Treatment Drug Sales Market Share by Type (2020-2025)
6.3 Global Invasive Candidiasis Treatment Drug Market Size by Type (2020-2025)
6.4 Global Invasive Candidiasis Treatment Drug Price by Type (2020-2025)
7 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Invasive Candidiasis Treatment Drug Market Sales by Application (2020-2025)
7.3 Global Invasive Candidiasis Treatment Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Invasive Candidiasis Treatment Drug Sales Growth Rate by Application (2020-2025)
8 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET SALES BY REGION
8.1 Global Invasive Candidiasis Treatment Drug Sales by Region
8.1.1 Global Invasive Candidiasis Treatment Drug Sales by Region
8.1.2 Global Invasive Candidiasis Treatment Drug Sales Market Share by Region
8.2 Global Invasive Candidiasis Treatment Drug Market Size by Region
8.2.1 Global Invasive Candidiasis Treatment Drug Market Size by Region
8.2.2 Global Invasive Candidiasis Treatment Drug Market Size by Region
8.3 North America
8.3.1 North America Invasive Candidiasis Treatment Drug Sales by Country
8.3.2 North America Invasive Candidiasis Treatment Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Invasive Candidiasis Treatment Drug Sales by Country
8.4.2 Europe Invasive Candidiasis Treatment Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Invasive Candidiasis Treatment Drug Sales by Region
8.5.2 Asia Pacific Invasive Candidiasis Treatment Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Invasive Candidiasis Treatment Drug Sales by Country
8.6.2 South America Invasive Candidiasis Treatment Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Invasive Candidiasis Treatment Drug Sales by Region
8.7.2 Middle East and Africa Invasive Candidiasis Treatment Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Invasive Candidiasis Treatment Drug by Region(2020-2025)
9.2 Global Invasive Candidiasis Treatment Drug Revenue Market Share by Region (2020-2025)
9.3 Global Invasive Candidiasis Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Invasive Candidiasis Treatment Drug Production
9.4.1 North America Invasive Candidiasis Treatment Drug Production Growth Rate (2020-2025)
9.4.2 North America Invasive Candidiasis Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Invasive Candidiasis Treatment Drug Production
9.5.1 Europe Invasive Candidiasis Treatment Drug Production Growth Rate (2020-2025)
9.5.2 Europe Invasive Candidiasis Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Invasive Candidiasis Treatment Drug Production (2020-2025)
9.6.1 Japan Invasive Candidiasis Treatment Drug Production Growth Rate (2020-2025)
9.6.2 Japan Invasive Candidiasis Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Invasive Candidiasis Treatment Drug Production (2020-2025)
9.7.1 China Invasive Candidiasis Treatment Drug Production Growth Rate (2020-2025)
9.7.2 China Invasive Candidiasis Treatment Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 GlaxoSmithKline
10.1.1 GlaxoSmithKline Basic Information
10.1.2 GlaxoSmithKline Invasive Candidiasis Treatment Drug Product Overview
10.1.3 GlaxoSmithKline Invasive Candidiasis Treatment Drug Product Market Performance
10.1.4 GlaxoSmithKline Business Overview
10.1.5 GlaxoSmithKline SWOT Analysis
10.1.6 GlaxoSmithKline Recent Developments
10.2 Merck and Co., Inc
10.2.1 Merck and Co., Inc Basic Information
10.2.2 Merck and Co., Inc Invasive Candidiasis Treatment Drug Product Overview
10.2.3 Merck and Co., Inc Invasive Candidiasis Treatment Drug Product Market Performance
10.2.4 Merck and Co., Inc Business Overview
10.2.5 Merck and Co., Inc SWOT Analysis
10.2.6 Merck and Co., Inc Recent Developments
10.3 Pfizer Inc
10.3.1 Pfizer Inc Basic Information
10.3.2 Pfizer Inc Invasive Candidiasis Treatment Drug Product Overview
10.3.3 Pfizer Inc Invasive Candidiasis Treatment Drug Product Market Performance
10.3.4 Pfizer Inc Business Overview
10.3.5 Pfizer Inc SWOT Analysis
10.3.6 Pfizer Inc Recent Developments
10.4 Cidara Therapeutics, Inc
10.4.1 Cidara Therapeutics, Inc Basic Information
10.4.2 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product Overview
10.4.3 Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product Market Performance
10.4.4 Cidara Therapeutics, Inc Business Overview
10.4.5 Cidara Therapeutics, Inc Recent Developments
10.5 Astellas Pharma Inc
10.5.1 Astellas Pharma Inc Basic Information
10.5.2 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product Overview
10.5.3 Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product Market Performance
10.5.4 Astellas Pharma Inc Business Overview
10.5.5 Astellas Pharma Inc Recent Developments
10.6 Gilead Sciences, Inc
10.6.1 Gilead Sciences, Inc Basic Information
10.6.2 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product Overview
10.6.3 Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product Market Performance
10.6.4 Gilead Sciences, Inc Business Overview
10.6.5 Gilead Sciences, Inc Recent Developments
10.7 Novo Nordisk A/S (Xellia Pharmaceuticals)
10.7.1 Novo Nordisk A/S (Xellia Pharmaceuticals) Basic Information
10.7.2 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product Overview
10.7.3 Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product Market Performance
10.7.4 Novo Nordisk A/S (Xellia Pharmaceuticals) Business Overview
10.7.5 Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Developments
10.8 Biosergen AB
10.8.1 Biosergen AB Basic Information
10.8.2 Biosergen AB Invasive Candidiasis Treatment Drug Product Overview
10.8.3 Biosergen AB Invasive Candidiasis Treatment Drug Product Market Performance
10.8.4 Biosergen AB Business Overview
10.8.5 Biosergen AB Recent Developments
10.9 Matinas BioPharma Holdings, Inc
10.9.1 Matinas BioPharma Holdings, Inc Basic Information
10.9.2 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product Overview
10.9.3 Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product Market Performance
10.9.4 Matinas BioPharma Holdings, Inc Business Overview
10.9.5 Matinas BioPharma Holdings, Inc Recent Developments
10.10 Pulmocide Ltd
10.10.1 Pulmocide Ltd Basic Information
10.10.2 Pulmocide Ltd Invasive Candidiasis Treatment Drug Product Overview
10.10.3 Pulmocide Ltd Invasive Candidiasis Treatment Drug Product Market Performance
10.10.4 Pulmocide Ltd Business Overview
10.10.5 Pulmocide Ltd Recent Developments
10.11 F2G Ltd
10.11.1 F2G Ltd Basic Information
10.11.2 F2G Ltd Invasive Candidiasis Treatment Drug Product Overview
10.11.3 F2G Ltd Invasive Candidiasis Treatment Drug Product Market Performance
10.11.4 F2G Ltd Business Overview
10.11.5 F2G Ltd Recent Developments
11 INVASIVE CANDIDIASIS TREATMENT DRUG MARKET FORECAST BY REGION
11.1 Global Invasive Candidiasis Treatment Drug Market Size Forecast
11.2 Global Invasive Candidiasis Treatment Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Invasive Candidiasis Treatment Drug Market Size Forecast by Country
11.2.3 Asia Pacific Invasive Candidiasis Treatment Drug Market Size Forecast by Region
11.2.4 South America Invasive Candidiasis Treatment Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Invasive Candidiasis Treatment Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Invasive Candidiasis Treatment Drug Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Invasive Candidiasis Treatment Drug by Type (2026-2035)
12.1.2 Global Invasive Candidiasis Treatment Drug Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Invasive Candidiasis Treatment Drug by Type (2026-2035)
12.2 Global Invasive Candidiasis Treatment Drug Market Forecast by Application (2026-2035)
12.2.1 Global Invasive Candidiasis Treatment Drug Sales (K Units) Forecast by Application
12.2.2 Global Invasive Candidiasis Treatment Drug Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Invasive Candidiasis Treatment Drug Market Size by Type (M USD)
Table 4. Global Invasive Candidiasis Treatment Drug Market Size by Application
Table 5. Invasive Candidiasis Treatment Drug Market Size Comparison by Region (M USD)
Table 6. Global Invasive Candidiasis Treatment Drug Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Invasive Candidiasis Treatment Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Invasive Candidiasis Treatment Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Invasive Candidiasis Treatment Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Candidiasis Treatment Drug as of 2025)
Table 11. Global Market Invasive Candidiasis Treatment Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Invasive Candidiasis Treatment Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Invasive Candidiasis Treatment Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Invasive Candidiasis Treatment Drug Sales by Type (K Units)
Table 27. Global Invasive Candidiasis Treatment Drug Market Size by Type (M USD)
Table 28. Global Invasive Candidiasis Treatment Drug Sales (K Units) by Type (2020-2025)
Table 29. Global Invasive Candidiasis Treatment Drug Sales Market Share by Type (2020-2025)
Table 30. Global Invasive Candidiasis Treatment Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Invasive Candidiasis Treatment Drug Market Share by Type (2020-2025)
Table 32. Global Invasive Candidiasis Treatment Drug Price (USD/Unit) by Type (2020-2025)
Table 33. Global Invasive Candidiasis Treatment Drug Sales (K Units) by Application
Table 34. Global Invasive Candidiasis Treatment Drug Market Size by Application
Table 35. Global Invasive Candidiasis Treatment Drug Sales by Application (2020-2025) & (K Units)
Table 36. Global Invasive Candidiasis Treatment Drug Sales Market Share by Application (2020-2025)
Table 37. Global Invasive Candidiasis Treatment Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Invasive Candidiasis Treatment Drug Market Share by Application (2020-2025)
Table 39. Global Invasive Candidiasis Treatment Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Invasive Candidiasis Treatment Drug Sales by Region (2020-2025) & (K Units)
Table 41. Global Invasive Candidiasis Treatment Drug Sales Market Share by Region (2020-2025)
Table 42. Global Invasive Candidiasis Treatment Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Invasive Candidiasis Treatment Drug Market Size by Region (2020-2025)
Table 44. North America Invasive Candidiasis Treatment Drug Sales by Country (2020-2025) & (K Units)
Table 45. North America Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Invasive Candidiasis Treatment Drug Sales by Country (2020-2025) & (K Units)
Table 47. Europe Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Invasive Candidiasis Treatment Drug Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Invasive Candidiasis Treatment Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Invasive Candidiasis Treatment Drug Sales by Country (2020-2025) & (K Units)
Table 51. South America Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Invasive Candidiasis Treatment Drug Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Invasive Candidiasis Treatment Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Invasive Candidiasis Treatment Drug Production (K Units) by Region(2020-2025)
Table 55. Global Invasive Candidiasis Treatment Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Invasive Candidiasis Treatment Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Invasive Candidiasis Treatment Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Invasive Candidiasis Treatment Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Invasive Candidiasis Treatment Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Invasive Candidiasis Treatment Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. GlaxoSmithKline Basic Information
Table 63. GlaxoSmithKline Invasive Candidiasis Treatment Drug Product Overview
Table 64. GlaxoSmithKline Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline SWOT Analysis
Table 67. GlaxoSmithKline Recent Developments
Table 68. Merck and Co., Inc Basic Information
Table 69. Merck and Co., Inc Invasive Candidiasis Treatment Drug Product Overview
Table 70. Merck and Co., Inc Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Merck and Co., Inc Business Overview
Table 72. Merck and Co., Inc SWOT Analysis
Table 73. Merck and Co., Inc Recent Developments
Table 74. Pfizer Inc Basic Information
Table 75. Pfizer Inc Invasive Candidiasis Treatment Drug Product Overview
Table 76. Pfizer Inc Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Pfizer Inc Business Overview
Table 78. Pfizer Inc SWOT Analysis
Table 79. Pfizer Inc Recent Developments
Table 80. Cidara Therapeutics, Inc Basic Information
Table 81. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product Overview
Table 82. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Cidara Therapeutics, Inc Business Overview
Table 84. Cidara Therapeutics, Inc Recent Developments
Table 85. Astellas Pharma Inc Basic Information
Table 86. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product Overview
Table 87. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Astellas Pharma Inc Business Overview
Table 89. Astellas Pharma Inc Recent Developments
Table 90. Gilead Sciences, Inc Basic Information
Table 91. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product Overview
Table 92. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Gilead Sciences, Inc Business Overview
Table 94. Gilead Sciences, Inc Recent Developments
Table 95. Novo Nordisk A/S (Xellia Pharmaceuticals) Basic Information
Table 96. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product Overview
Table 97. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Novo Nordisk A/S (Xellia Pharmaceuticals) Business Overview
Table 99. Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Developments
Table 100. Biosergen AB Basic Information
Table 101. Biosergen AB Invasive Candidiasis Treatment Drug Product Overview
Table 102. Biosergen AB Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Biosergen AB Business Overview
Table 104. Biosergen AB Recent Developments
Table 105. Matinas BioPharma Holdings, Inc Basic Information
Table 106. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product Overview
Table 107. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Matinas BioPharma Holdings, Inc Business Overview
Table 109. Matinas BioPharma Holdings, Inc Recent Developments
Table 110. Pulmocide Ltd Basic Information
Table 111. Pulmocide Ltd Invasive Candidiasis Treatment Drug Product Overview
Table 112. Pulmocide Ltd Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Pulmocide Ltd Business Overview
Table 114. Pulmocide Ltd Recent Developments
Table 115. F2G Ltd Basic Information
Table 116. F2G Ltd Invasive Candidiasis Treatment Drug Product Overview
Table 117. F2G Ltd Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. F2G Ltd Business Overview
Table 119. F2G Ltd Recent Developments
Table 120. Global Invasive Candidiasis Treatment Drug Sales Forecast by Region (2026-2035) & (K Units)
Table 121. Global Invasive Candidiasis Treatment Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Invasive Candidiasis Treatment Drug Sales Forecast by Country (2026-2035) & (K Units)
Table 123. North America Invasive Candidiasis Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Invasive Candidiasis Treatment Drug Sales Forecast by Country (2026-2035) & (K Units)
Table 125. Europe Invasive Candidiasis Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Invasive Candidiasis Treatment Drug Sales Forecast by Region (2026-2035) & (K Units)
Table 127. Asia Pacific Invasive Candidiasis Treatment Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Invasive Candidiasis Treatment Drug Sales Forecast by Country (2026-2035) & (K Units)
Table 129. South America Invasive Candidiasis Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Invasive Candidiasis Treatment Drug Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Invasive Candidiasis Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Invasive Candidiasis Treatment Drug Sales Forecast by Type (2026-2035) & (K Units)
Table 133. Global Invasive Candidiasis Treatment Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Invasive Candidiasis Treatment Drug Price Forecast by Type (2026-2035) & (USD/Unit)
Table 135. Global Invasive Candidiasis Treatment Drug Sales (K Units) Forecast by Application (2026-2035)
Table 136. Global Invasive Candidiasis Treatment Drug Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Invasive Candidiasis Treatment Drug Market Size by Type (M USD)
Table 4. Global Invasive Candidiasis Treatment Drug Market Size by Application
Table 5. Invasive Candidiasis Treatment Drug Market Size Comparison by Region (M USD)
Table 6. Global Invasive Candidiasis Treatment Drug Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Invasive Candidiasis Treatment Drug Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Invasive Candidiasis Treatment Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Invasive Candidiasis Treatment Drug Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Invasive Candidiasis Treatment Drug as of 2025)
Table 11. Global Market Invasive Candidiasis Treatment Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Invasive Candidiasis Treatment Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Invasive Candidiasis Treatment Drug Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Invasive Candidiasis Treatment Drug Sales by Type (K Units)
Table 27. Global Invasive Candidiasis Treatment Drug Market Size by Type (M USD)
Table 28. Global Invasive Candidiasis Treatment Drug Sales (K Units) by Type (2020-2025)
Table 29. Global Invasive Candidiasis Treatment Drug Sales Market Share by Type (2020-2025)
Table 30. Global Invasive Candidiasis Treatment Drug Market Size (M USD) by Type (2020-2025)
Table 31. Global Invasive Candidiasis Treatment Drug Market Share by Type (2020-2025)
Table 32. Global Invasive Candidiasis Treatment Drug Price (USD/Unit) by Type (2020-2025)
Table 33. Global Invasive Candidiasis Treatment Drug Sales (K Units) by Application
Table 34. Global Invasive Candidiasis Treatment Drug Market Size by Application
Table 35. Global Invasive Candidiasis Treatment Drug Sales by Application (2020-2025) & (K Units)
Table 36. Global Invasive Candidiasis Treatment Drug Sales Market Share by Application (2020-2025)
Table 37. Global Invasive Candidiasis Treatment Drug Market Size by Application (2020-2025) & (M USD)
Table 38. Global Invasive Candidiasis Treatment Drug Market Share by Application (2020-2025)
Table 39. Global Invasive Candidiasis Treatment Drug Sales Growth Rate by Application (2020-2025)
Table 40. Global Invasive Candidiasis Treatment Drug Sales by Region (2020-2025) & (K Units)
Table 41. Global Invasive Candidiasis Treatment Drug Sales Market Share by Region (2020-2025)
Table 42. Global Invasive Candidiasis Treatment Drug Market Size by Region (2020-2025) & (M USD)
Table 43. Global Invasive Candidiasis Treatment Drug Market Size by Region (2020-2025)
Table 44. North America Invasive Candidiasis Treatment Drug Sales by Country (2020-2025) & (K Units)
Table 45. North America Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Invasive Candidiasis Treatment Drug Sales by Country (2020-2025) & (K Units)
Table 47. Europe Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Invasive Candidiasis Treatment Drug Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Invasive Candidiasis Treatment Drug Market Size by Region (2020-2025) & (M USD)
Table 50. South America Invasive Candidiasis Treatment Drug Sales by Country (2020-2025) & (K Units)
Table 51. South America Invasive Candidiasis Treatment Drug Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Invasive Candidiasis Treatment Drug Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Invasive Candidiasis Treatment Drug Market Size by Region (2020-2025) & (M USD)
Table 54. Global Invasive Candidiasis Treatment Drug Production (K Units) by Region(2020-2025)
Table 55. Global Invasive Candidiasis Treatment Drug Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Invasive Candidiasis Treatment Drug Revenue Market Share by Region (2020-2025)
Table 57. Global Invasive Candidiasis Treatment Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Invasive Candidiasis Treatment Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Invasive Candidiasis Treatment Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Invasive Candidiasis Treatment Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Invasive Candidiasis Treatment Drug Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. GlaxoSmithKline Basic Information
Table 63. GlaxoSmithKline Invasive Candidiasis Treatment Drug Product Overview
Table 64. GlaxoSmithKline Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. GlaxoSmithKline Business Overview
Table 66. GlaxoSmithKline SWOT Analysis
Table 67. GlaxoSmithKline Recent Developments
Table 68. Merck and Co., Inc Basic Information
Table 69. Merck and Co., Inc Invasive Candidiasis Treatment Drug Product Overview
Table 70. Merck and Co., Inc Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Merck and Co., Inc Business Overview
Table 72. Merck and Co., Inc SWOT Analysis
Table 73. Merck and Co., Inc Recent Developments
Table 74. Pfizer Inc Basic Information
Table 75. Pfizer Inc Invasive Candidiasis Treatment Drug Product Overview
Table 76. Pfizer Inc Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Pfizer Inc Business Overview
Table 78. Pfizer Inc SWOT Analysis
Table 79. Pfizer Inc Recent Developments
Table 80. Cidara Therapeutics, Inc Basic Information
Table 81. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Product Overview
Table 82. Cidara Therapeutics, Inc Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Cidara Therapeutics, Inc Business Overview
Table 84. Cidara Therapeutics, Inc Recent Developments
Table 85. Astellas Pharma Inc Basic Information
Table 86. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Product Overview
Table 87. Astellas Pharma Inc Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Astellas Pharma Inc Business Overview
Table 89. Astellas Pharma Inc Recent Developments
Table 90. Gilead Sciences, Inc Basic Information
Table 91. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Product Overview
Table 92. Gilead Sciences, Inc Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Gilead Sciences, Inc Business Overview
Table 94. Gilead Sciences, Inc Recent Developments
Table 95. Novo Nordisk A/S (Xellia Pharmaceuticals) Basic Information
Table 96. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Product Overview
Table 97. Novo Nordisk A/S (Xellia Pharmaceuticals) Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Novo Nordisk A/S (Xellia Pharmaceuticals) Business Overview
Table 99. Novo Nordisk A/S (Xellia Pharmaceuticals) Recent Developments
Table 100. Biosergen AB Basic Information
Table 101. Biosergen AB Invasive Candidiasis Treatment Drug Product Overview
Table 102. Biosergen AB Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Biosergen AB Business Overview
Table 104. Biosergen AB Recent Developments
Table 105. Matinas BioPharma Holdings, Inc Basic Information
Table 106. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Product Overview
Table 107. Matinas BioPharma Holdings, Inc Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Matinas BioPharma Holdings, Inc Business Overview
Table 109. Matinas BioPharma Holdings, Inc Recent Developments
Table 110. Pulmocide Ltd Basic Information
Table 111. Pulmocide Ltd Invasive Candidiasis Treatment Drug Product Overview
Table 112. Pulmocide Ltd Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Pulmocide Ltd Business Overview
Table 114. Pulmocide Ltd Recent Developments
Table 115. F2G Ltd Basic Information
Table 116. F2G Ltd Invasive Candidiasis Treatment Drug Product Overview
Table 117. F2G Ltd Invasive Candidiasis Treatment Drug Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. F2G Ltd Business Overview
Table 119. F2G Ltd Recent Developments
Table 120. Global Invasive Candidiasis Treatment Drug Sales Forecast by Region (2026-2035) & (K Units)
Table 121. Global Invasive Candidiasis Treatment Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 122. North America Invasive Candidiasis Treatment Drug Sales Forecast by Country (2026-2035) & (K Units)
Table 123. North America Invasive Candidiasis Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 124. Europe Invasive Candidiasis Treatment Drug Sales Forecast by Country (2026-2035) & (K Units)
Table 125. Europe Invasive Candidiasis Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Asia Pacific Invasive Candidiasis Treatment Drug Sales Forecast by Region (2026-2035) & (K Units)
Table 127. Asia Pacific Invasive Candidiasis Treatment Drug Market Size Forecast by Region (2026-2035) & (M USD)
Table 128. South America Invasive Candidiasis Treatment Drug Sales Forecast by Country (2026-2035) & (K Units)
Table 129. South America Invasive Candidiasis Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 130. Middle East and Africa Invasive Candidiasis Treatment Drug Sales Forecast by Country (2026-2035) & (Units)
Table 131. Middle East and Africa Invasive Candidiasis Treatment Drug Market Size Forecast by Country (2026-2035) & (M USD)
Table 132. Global Invasive Candidiasis Treatment Drug Sales Forecast by Type (2026-2035) & (K Units)
Table 133. Global Invasive Candidiasis Treatment Drug Market Size Forecast by Type (2026-2035) & (M USD)
Table 134. Global Invasive Candidiasis Treatment Drug Price Forecast by Type (2026-2035) & (USD/Unit)
Table 135. Global Invasive Candidiasis Treatment Drug Sales (K Units) Forecast by Application (2026-2035)
Table 136. Global Invasive Candidiasis Treatment Drug Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Invasive Candidiasis Treatment Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Invasive Candidiasis Treatment Drug Market Size (M USD), 2025-2035
Figure 5. Global Invasive Candidiasis Treatment Drug Market Size (M USD) (2020-2035)
Figure 6. Global Invasive Candidiasis Treatment Drug Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Invasive Candidiasis Treatment Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Invasive Candidiasis Treatment Drug Product Life Cycle
Figure 13. Invasive Candidiasis Treatment Drug Sales Share by Manufacturers in 2025
Figure 14. Global Invasive Candidiasis Treatment Drug Revenue Share by Manufacturers in 2025
Figure 15. Invasive Candidiasis Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Invasive Candidiasis Treatment Drug Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Invasive Candidiasis Treatment Drug Revenue in 2025
Figure 18. Industry Chain Map of Invasive Candidiasis Treatment Drug
Figure 19. Global Invasive Candidiasis Treatment Drug Market PEST Analysis
Figure 20. Global Invasive Candidiasis Treatment Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Invasive Candidiasis Treatment Drug Market Share by Type
Figure 27. Sales Market Share of Invasive Candidiasis Treatment Drug by Type (2020-2025)
Figure 28. Sales Market Share of Invasive Candidiasis Treatment Drug by Type in 2025
Figure 29. Market Share of Invasive Candidiasis Treatment Drug by Type (2020-2025)
Figure 30. Market Share of Invasive Candidiasis Treatment Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Invasive Candidiasis Treatment Drug Market Share by Application
Figure 33. Global Invasive Candidiasis Treatment Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Invasive Candidiasis Treatment Drug Sales Market Share by Application in 2025
Figure 35. Global Invasive Candidiasis Treatment Drug Market Share by Application (2020-2025)
Figure 36. Global Invasive Candidiasis Treatment Drug Market Share by Application in 2025
Figure 37. Global Invasive Candidiasis Treatment Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Invasive Candidiasis Treatment Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Invasive Candidiasis Treatment Drug Market Size by Region (2020-2025)
Figure 40. North America Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Invasive Candidiasis Treatment Drug Sales Market Share by Country in 2024
Figure 43. North America Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Invasive Candidiasis Treatment Drug Market Size by Country in 2024
Figure 45. U.S. Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Invasive Candidiasis Treatment Drug Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Invasive Candidiasis Treatment Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Invasive Candidiasis Treatment Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Invasive Candidiasis Treatment Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Invasive Candidiasis Treatment Drug Sales Market Share by Country in 2024
Figure 53. Europe Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Invasive Candidiasis Treatment Drug Market Size by Country in 2024
Figure 55. Germany Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Invasive Candidiasis Treatment Drug Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Invasive Candidiasis Treatment Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Invasive Candidiasis Treatment Drug Market Size by Region in 2024
Figure 68. China Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Invasive Candidiasis Treatment Drug Sales and Growth Rate (K Units)
Figure 79. South America Invasive Candidiasis Treatment Drug Sales Market Share by Country in 2024
Figure 80. South America Invasive Candidiasis Treatment Drug Market Size and Growth Rate (M USD)
Figure 81. South America Invasive Candidiasis Treatment Drug Market Size by Country in 2024
Figure 82. Brazil Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Invasive Candidiasis Treatment Drug Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Invasive Candidiasis Treatment Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Invasive Candidiasis Treatment Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Invasive Candidiasis Treatment Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Invasive Candidiasis Treatment Drug Production Market Share by Region (2020-2025)
Figure 103. North America Invasive Candidiasis Treatment Drug Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Invasive Candidiasis Treatment Drug Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Invasive Candidiasis Treatment Drug Production (K Units) Growth Rate (2020-2025)
Figure 106. China Invasive Candidiasis Treatment Drug Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Invasive Candidiasis Treatment Drug Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Invasive Candidiasis Treatment Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Invasive Candidiasis Treatment Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Invasive Candidiasis Treatment Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Invasive Candidiasis Treatment Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Invasive Candidiasis Treatment Drug Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Invasive Candidiasis Treatment Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Invasive Candidiasis Treatment Drug Market Size (M USD), 2025-2035
Figure 5. Global Invasive Candidiasis Treatment Drug Market Size (M USD) (2020-2035)
Figure 6. Global Invasive Candidiasis Treatment Drug Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Invasive Candidiasis Treatment Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Invasive Candidiasis Treatment Drug Product Life Cycle
Figure 13. Invasive Candidiasis Treatment Drug Sales Share by Manufacturers in 2025
Figure 14. Global Invasive Candidiasis Treatment Drug Revenue Share by Manufacturers in 2025
Figure 15. Invasive Candidiasis Treatment Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Invasive Candidiasis Treatment Drug Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Invasive Candidiasis Treatment Drug Revenue in 2025
Figure 18. Industry Chain Map of Invasive Candidiasis Treatment Drug
Figure 19. Global Invasive Candidiasis Treatment Drug Market PEST Analysis
Figure 20. Global Invasive Candidiasis Treatment Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Invasive Candidiasis Treatment Drug Market Share by Type
Figure 27. Sales Market Share of Invasive Candidiasis Treatment Drug by Type (2020-2025)
Figure 28. Sales Market Share of Invasive Candidiasis Treatment Drug by Type in 2025
Figure 29. Market Share of Invasive Candidiasis Treatment Drug by Type (2020-2025)
Figure 30. Market Share of Invasive Candidiasis Treatment Drug by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Invasive Candidiasis Treatment Drug Market Share by Application
Figure 33. Global Invasive Candidiasis Treatment Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Invasive Candidiasis Treatment Drug Sales Market Share by Application in 2025
Figure 35. Global Invasive Candidiasis Treatment Drug Market Share by Application (2020-2025)
Figure 36. Global Invasive Candidiasis Treatment Drug Market Share by Application in 2025
Figure 37. Global Invasive Candidiasis Treatment Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Invasive Candidiasis Treatment Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Invasive Candidiasis Treatment Drug Market Size by Region (2020-2025)
Figure 40. North America Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Invasive Candidiasis Treatment Drug Sales Market Share by Country in 2024
Figure 43. North America Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Invasive Candidiasis Treatment Drug Market Size by Country in 2024
Figure 45. U.S. Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Invasive Candidiasis Treatment Drug Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Invasive Candidiasis Treatment Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Invasive Candidiasis Treatment Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Invasive Candidiasis Treatment Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Invasive Candidiasis Treatment Drug Sales Market Share by Country in 2024
Figure 53. Europe Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Invasive Candidiasis Treatment Drug Market Size by Country in 2024
Figure 55. Germany Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Invasive Candidiasis Treatment Drug Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Invasive Candidiasis Treatment Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Invasive Candidiasis Treatment Drug Market Size by Region in 2024
Figure 68. China Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Invasive Candidiasis Treatment Drug Sales and Growth Rate (K Units)
Figure 79. South America Invasive Candidiasis Treatment Drug Sales Market Share by Country in 2024
Figure 80. South America Invasive Candidiasis Treatment Drug Market Size and Growth Rate (M USD)
Figure 81. South America Invasive Candidiasis Treatment Drug Market Size by Country in 2024
Figure 82. Brazil Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Invasive Candidiasis Treatment Drug Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Invasive Candidiasis Treatment Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Invasive Candidiasis Treatment Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Invasive Candidiasis Treatment Drug Market Size by Region in 2024
Figure 92. Saudi Arabia Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Invasive Candidiasis Treatment Drug Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Invasive Candidiasis Treatment Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Invasive Candidiasis Treatment Drug Production Market Share by Region (2020-2025)
Figure 103. North America Invasive Candidiasis Treatment Drug Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Invasive Candidiasis Treatment Drug Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Invasive Candidiasis Treatment Drug Production (K Units) Growth Rate (2020-2025)
Figure 106. China Invasive Candidiasis Treatment Drug Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Invasive Candidiasis Treatment Drug Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Invasive Candidiasis Treatment Drug Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Invasive Candidiasis Treatment Drug Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Invasive Candidiasis Treatment Drug Market Share Forecast by Type (2026-2035)
Figure 111. Global Invasive Candidiasis Treatment Drug Sales Forecast by Application (2026-2035)
Figure 112. Global Invasive Candidiasis Treatment Drug Market Share Forecast by Application (2026-2035)
